NIH-funded research R21 grant

How well SMS reminders help cisgender women in Kenya stay on HIV PrEP

Official title: Mechanisms of Action for mobile SMS PrEP adherence intervention

Funded at University of Washington · NIH-11580109 · Data updated 2026-11-12

A small study tests how two-way text message reminders and conversations help pregnant and postpartum women in Kenya stick to HIV PrEP.

More PrEP research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startJuly 25, 2025
Project endJune 30, 2027
Funding year2026
Award (this year)$62,076
NIH project number3R21NR021354-02S1
Project IDNIH-11580109 on NIH RePORTER

Who could benefit from this research

Could help

Cisgender women in pregnancy or within the postpartum period at participating Kenyan clinics who are using or eligible for PrEP.

Less likely to help

Women not using PrEP or not in Kenya may not directly benefit from this MoA-focused study.

What this research studies

This project looks at why digital SMS reminders might help women take HIV PrEP by exploring real-life use at several public antenatal clinics in Kenya. It builds on an ongoing trial to identify the key mechanisms that make mobile health messages effective and how they can be tailored to different groups. The aim is to understand which aspects of the messages - such as content, timing, and interactivity - most strongly influence adherence and continuation of PrEP after pregnancy. Findings could guide practical improvements to digital health tools used to prevent HIV in high-prevalence settings.

Why it matters

Potential benefit: If successful, the study could inform better digital strategies to help women maintain PrEP use, reducing HIV risk.

How similar studies have gone: Previous work shows mixed results for digital health adherence tools, with a need for clearer mechanisms of action; this study directly addresses that gap.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Wagner, Anjuli Dawn — University of Washington
  • Study coordinator: Wagner, Anjuli Dawn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.